Medical Condition News

RSS

Biologics receives National Comprehensive Cancer Network recognition

Biologics, Inc., an oncology management company, has been recognized by the National Comprehensive Cancer Network® (NCCN®) for its commitment to supporting patient access to quality oncology care. For the first time, the NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is recognizing commercial payor and non-payor organizations, including Biologics, which support the appropriate, effective, and efficient use of oncology treatment and care of patients through its new NCCN Recognition Program.

11 Jan 2011

NPS completes treatment phase in GATTEX Phase 3 registration study in short bowel syndrome

NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).

11 Jan 2011

MSU researcher believes pregnancy unmasks predispositions to cardiovascular disease

As the rate of preterm delivery rises - accounting for 12.5 percent of all U.S. births - a Michigan State University epidemiologist is using a $3.7 million federal grant to uncover why some mothers who deliver babies early are at an increased risk of developing cardiovascular disease.

11 Jan 2011

American Heart Association: CPR training is essential for all secondary school students

All secondary school students should be required to be trained in cardiopulmonary resuscitation and receive an overview of automated external defibrillators, according to an American Heart Association science advisory.

11 Jan 2011

Amount of alcohol and pattern of consumption affect risk of cognitive impairment

Previous research regarding the association between alcohol consumption and dementia or cognitive impairment in later life suggests that mild to moderate alcohol consumption might be protective of dementia. However, most of the research has been conducted on subjects already rather elderly at the start of the follow-up. A new study published in the December issue of the Journal of Alzheimer's Disease addresses this problem with a follow-up of more than two decades.

11 Jan 2011

Nationwide Children's Hospital receives $11.5 million NCI grant for Biospecimen banking

Nationwide Children's Hospital was awarded $11.5 million from the National Cancer Institute late last year to continue its role as one of two Biospecimen Core Resources for The Cancer Genome Atlas.

11 Jan 2011

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Physicians at Baylor Jack and Jane Hamilton Heart and Vascular Hospital are the first in North Texas to offer the Arctic Front® Cardiac CryoAblation Catheter system, the first and only cryoballoon in the United States indicated to treat drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder that affects millions of Americans.

11 Jan 2011

Plasminogen may serve as new target to treat prion diseases

Scientists at the University of Kentucky have discovered that plasminogen, a protein used by the body to break up blood clots, speeds up the progress of prion diseases such as mad cow disease.

11 Jan 2011

Nutriceuticals may restore age-related vision loss

While age-related vision loss of catastrophic proportions is predicted in coming decades, rising from 17 million patients today to 55 million by the year 2050, it's possible this catastrophe could be averted and lost vision even restored using molecular medicine.

11 Jan 2011

MDCT provides efficient way to analyze wounds from bullets and explosive devices

Multidetector computed tomography provides an efficient, effective way to analyze wounds from bullets and explosive devices, according to a study published online and in the March issue of Radiology.

11 Jan 2011

New guidelines for accurate diagnosis, effective ethical treatment of postmenopausal osteoporosis

Today the American Association of Clinical Endocrinologists released new medical guidelines for the accurate diagnosis and effective ethical treatment of postmenopausal osteoporosis in affected patients.

11 Jan 2011

Lineagen introduces FirstStep integrated genetic testing for early diagnostic evaluation of ASD, DD

Lineagen announces the launch of its FirstStep integrated genetic testing and counseling service to assist pediatricians and family physicians with the earlier, more accurate diagnostic evaluation of autism spectrum disorders and developmental delay.

11 Jan 2011

GSK, Epizyme enter partnership to discover, develop, and market epigenetic therapeutics

Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.

11 Jan 2011

New insights into estrogen receptor beta

Research with significant implications in the treatment and intervention of cancer and obesity has been published recently in two prestigious journals by University of Houston (UH) biochemist Dr. Jan--ke Gustafsson.

11 Jan 2011

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.

11 Jan 2011

Opsens files patent application for OptoWire diagnostic tool for measuring FFR

Opsens announces that it has recently filed a patent application for the OptoWire, a second diagnostic tool to assess coronary lesions by doing Fractional Flow Reserve.

10 Jan 2011

Ifa Systems acquires inoveon

ifa Systems AG, the global leader for IT solutions in ophthalmology based in Cologne, Germany, announced the acquisition of inoveon Corporation, proven experts in detection, staging, and monitoring of diabetic retinopathy and macular edema.

10 Jan 2011

Enobia Pharma completes ENB-0040 Phase II study in juveniles with hypophosphatasia

Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.

10 Jan 2011

Multiple sclerosis gene connection from women to offspring: Study

A new study has shown that women pass on the multiple sclerosis (MS) gene more commonly than men to their offspring. The team analyzed DNA of more than 7,000 people and found that women were also more likely to pass on the gene to female relatives. This may explain why women are up to three times more likely to get MS than men. The study was funded by the MS Society and led by George Ebers at Oxford University. It was published in the journal Neurology.

10 Jan 2011

World's first drug eluting bioresorbable vascular scaffold receives CE Mark approval

Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.

10 Jan 2011

Medical Condition News

Biologics receives National Comprehensive Cancer Network recognition

NPS completes treatment phase in GATTEX Phase 3 registration study in short bowel syndrome

MSU researcher believes pregnancy unmasks predispositions to cardiovascular disease

American Heart Association: CPR training is essential for all secondary school students

Amount of alcohol and pattern of consumption affect risk of cognitive impairment

Nationwide Children's Hospital receives $11.5 million NCI grant for Biospecimen banking

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Plasminogen may serve as new target to treat prion diseases

Nutriceuticals may restore age-related vision loss

MDCT provides efficient way to analyze wounds from bullets and explosive devices

New guidelines for accurate diagnosis, effective ethical treatment of postmenopausal osteoporosis

Lineagen introduces FirstStep integrated genetic testing for early diagnostic evaluation of ASD, DD

GSK, Epizyme enter partnership to discover, develop, and market epigenetic therapeutics

New insights into estrogen receptor beta

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

Opsens files patent application for OptoWire diagnostic tool for measuring FFR

Ifa Systems acquires inoveon

Enobia Pharma completes ENB-0040 Phase II study in juveniles with hypophosphatasia

Multiple sclerosis gene connection from women to offspring: Study

World's first drug eluting bioresorbable vascular scaffold receives CE Mark approval

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News